Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Methods for monitoring gene gun-induced HBV- and HCV-specific immune responses in mouse models.

Ahlén G, Sällberg M, Frelin L.

Methods Mol Biol. 2013;940:239-67. doi: 10.1007/978-1-62703-110-3_20.

PMID:
23104348
2.

Heterologous T cells can help restore function in dysfunctional hepatitis C virus nonstructural 3/4A-specific T cells during therapeutic vaccination.

Chen A, Ahlén G, Brenndörfer ED, Brass A, Holmström F, Chen M, Söderholm J, Milich DR, Frelin L, Sällberg M.

J Immunol. 2011 May 1;186(9):5107-18. doi: 10.4049/jimmunol.1001790. Epub 2011 Mar 23.

3.

Cleavage of the IPS-1/Cardif/MAVS/VISA does not inhibit T cell-mediated elimination of hepatitis C virus non-structural 3/4A-expressing hepatocytes.

Ahlén G, Derk E, Weiland M, Jiao J, Rahbin N, Aleman S, Peterson DL, Pokrovskaja K, Grandér D, Frelin L, Sällberg M.

Gut. 2009 Apr;58(4):560-9. doi: 10.1136/gut.2007.147264. Epub 2008 Aug 8.

4.

DNA vaccine expressing the non-structural proteins of hepatitis C virus diminishes the expression of HCV proteins in a mouse model.

Wada T, Kohara M, Yasutomi Y.

Vaccine. 2013 Dec 5;31(50):5968-74. doi: 10.1016/j.vaccine.2013.10.037. Epub 2013 Oct 19.

PMID:
24144476
5.

[Expression and immune response to hepatitis C virus core gene combined hepatitis B virus core gene with two multiple cloning sites vector].

Deng T, Fan G, Chen T, Chen N, Hu D, Wang M, Jia K.

Zhonghua Yi Xue Za Zhi. 2002 Jan 25;82(2):77-80. Chinese.

PMID:
11953132
6.

Heat shock protein gp96 enhances humoral and T cell responses, decreases Treg frequency and potentiates the anti-HBV activity in BALB/c and transgenic mice.

Wang S, Qiu L, Liu G, Li Y, Zhang X, Jin W, Gao GF, Kong X, Meng S.

Vaccine. 2011 Aug 26;29(37):6342-51. doi: 10.1016/j.vaccine.2011.05.008. Epub 2011 May 19.

PMID:
21600951
7.
8.

Induction of strong hepatitis B virus (HBV) specific T helper cell and cytotoxic T lymphocyte responses by therapeutic vaccination in the trimera mouse model of chronic HBV infection.

Böcher WO, Dekel B, Schwerin W, Geissler M, Hoffmann S, Rohwer A, Arditti F, Cooper A, Bernhard H, Berrebi A, Rose-John S, Shaul Y, Galle PR, Löhr HF, Reisner Y.

Eur J Immunol. 2001 Jul;31(7):2071-9.

PMID:
11449360
9.

Absence of viral interference and different susceptibility to interferon between hepatitis B virus and hepatitis C virus in human hepatocyte chimeric mice.

Hiraga N, Imamura M, Hatakeyama T, Kitamura S, Mitsui F, Tanaka S, Tsuge M, Takahashi S, Abe H, Maekawa T, Ochi H, Tateno C, Yoshizato K, Wakita T, Chayama K.

J Hepatol. 2009 Dec;51(6):1046-54. doi: 10.1016/j.jhep.2009.09.002. Epub 2009 Sep 23.

PMID:
19853955
10.

Hepatitis C virus eradication associated with hepatitis B virus superinfection and development of a hepatitis B virus specific T cell response.

Gruener NH, Jung MC, Ulsenheimer A, Gerlach TJ, Diepolder HM, Schirren CA, Hoffmann R, Wächtler M, Backmund M, Pape GR.

J Hepatol. 2002 Dec;37(6):866-9.

PMID:
12445431
11.

Chimeric mouse model for the infection of hepatitis B and C viruses.

Tesfaye A, Stift J, Maric D, Cui Q, Dienes HP, Feinstone SM.

PLoS One. 2013 Oct 14;8(10):e77298. doi: 10.1371/journal.pone.0077298. eCollection 2013.

13.

Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.

Eyre NS, Phillips RJ, Bowden S, Yip E, Dewar B, Locarnini SA, Beard MR.

J Hepatol. 2009 Sep;51(3):446-57. doi: 10.1016/j.jhep.2009.04.025. Epub 2009 Jun 3.

PMID:
19596477
14.

DNA-based immunization breaks tolerance in a hepatitis C virus transgenic mouse model.

Encke J, Geissler M, Stremmel W, Wands JR.

Hum Vaccin. 2006 Mar-Apr;2(2):78-83. Epub 2006 Mar 23.

PMID:
17012868
15.

Generation of inducible hepatitis C virus transgenic mouse lines.

Ernst E, Schönig K, Bugert JJ, Bläker H, Pfaff E, Stremmel W, Encke J.

J Med Virol. 2007 Aug;79(8):1103-12.

PMID:
17596832
16.

A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.

Zeng R, Li G, Ling S, Zhang H, Yao Z, Xiu B, He F, Huang R, Wei L.

Antiviral Res. 2009 Oct;84(1):23-30. doi: 10.1016/j.antiviral.2009.07.011. Epub 2009 Jul 29.

PMID:
19646486
17.

Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection.

Yang PL, Althage A, Chung J, Chisari FV.

Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13825-30. Epub 2002 Oct 8.

18.
19.

Interference of replication between hepatitis B and C viruses in patients infected with HIV.

Yang RR, Gui X, Chen XY, Zhu Y.

J Med Virol. 2011 Jul;83(7):1159-64. doi: 10.1002/jmv.22102.

PMID:
21567419
20.

In vivo clearance of hepatitis C virus nonstructural 3/4A-expressing hepatocytes by DNA vaccine-primed cytotoxic T lymphocytes.

Ahlen G, Nystrom J, Pult I, Frelin L, Hultgren C, Sallberg M.

J Infect Dis. 2005 Dec 15;192(12):2112-6. Epub 2005 Nov 4.

PMID:
16288375

Supplemental Content

Support Center